MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products

John V. Duncia(DuPont (United States)), Richard E. Olson(Los Alamos National Laboratory), Margaret Favata(Wilmington University), F. Wayne Rankin(DuPont (United States)), Andrea J. Daulerio(Wilmington University), Ronald L. Magolda(Wilmington University), Peggy Scherle(Incyte (United States)), Elizabeth J. Manos(Wilmington University), A. Christine Tabaka(DuPont (United States)), C. Anne Higley(DuPont (United States)), William J. Pitts(Wilmington University), George L. Trainor(DuPont (United States)), William E. Frietze(DuPont (United States)), Deborah A. Stradley(Wilmington University), John Wityak(DuPont (United States)), Karl F. Blom(DuPont (United States)), Joseph B. Santella(DuPont (United States)), Frank W. Hobbs(Wilmington University), Robert A. Copeland(Epizyme (United States)), Kurumi Y. Horiuchi(Wilmington University), Richard A. Earl(Wilmington University), James M. Trzăskos(Bristol-Myers Squibb (United States)), Ruth R. Wexler(DuPont (United States)), Jung‐Hui Sun(DuPont (United States)), Christopher A. Teleha(DuPont (United States))
Bioorganic & Medicinal Chemistry Letters
October 1, 1998
Cited by 406


Related Papers